Discover undervalued stocks with Eulerpool.

Subscribe for $2

Stericycle Stock SRCL

Price

0
Today +/-
-0
Today %
-0 %

Stericycle stock price

Loading chart...
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Stericycle stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Stericycle stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Stericycle stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Stericycle's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Stericycle Stock Price History

DateStericycle Price
11/1/20240 undefined
10/31/202461.98 undefined
10/30/202461.47 undefined

Stericycle Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Stericycle, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Stericycle from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Stericycle’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Stericycle. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Stericycle’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Stericycle’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Stericycle’s growth potential.

Stericycle Revenue, EBIT and net profit per share

DateStericycle RevenueStericycle EBITStericycle Net Income
2029e3.45 B undefined0 undefined0 undefined
2028e3.29 B undefined0 undefined459.93 M undefined
2027e3.15 B undefined0 undefined417.52 M undefined
2026e3 B undefined489.6 M undefined342.12 M undefined
2025e2.86 B undefined389.95 M undefined262.95 M undefined
2024e2.78 B undefined313.09 M undefined213.94 M undefined
20232.66 B undefined266.9 M undefined-21.4 M undefined
20222.7 B undefined199.7 M undefined56 M undefined
20212.65 B undefined234.5 M undefined-27.8 M undefined
20202.68 B undefined254.6 M undefined-57.3 M undefined
20193.31 B undefined267.1 M undefined-346.8 M undefined
20183.49 B undefined459.6 M undefined-253.3 M undefined
20173.58 B undefined538.7 M undefined23.4 M undefined
20163.56 B undefined592.6 M undefined178.2 M undefined
20152.99 B undefined662.6 M undefined256.9 M undefined
20142.56 B undefined613.8 M undefined326.5 M undefined
20132.14 B undefined553.9 M undefined311.4 M undefined
20121.91 B undefined468.8 M undefined268 M undefined
20111.68 B undefined424.3 M undefined234.8 M undefined
20101.44 B undefined390.6 M undefined207.9 M undefined
20091.18 B undefined325.2 M undefined175.7 M undefined
20081.08 B undefined281.8 M undefined148.7 M undefined
2007932.8 M undefined241.2 M undefined118.4 M undefined
2006789.6 M undefined205.5 M undefined105.3 M undefined
2005609.5 M undefined167.5 M undefined67.2 M undefined
2004516.2 M undefined147.6 M undefined78.2 M undefined

Stericycle Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (B)
NET INCOME (M)
NET INCOME GROWTH (%)
SHARES (M)
DOCUMENTS
1991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e2029e
00.010.010.020.020.020.050.070.130.320.360.40.450.520.610.790.931.081.181.441.681.912.142.562.993.563.583.493.312.682.652.72.662.782.8633.153.293.45
-400.0080.0077.7831.2514.2991.6743.48100.00144.7011.1511.7012.9713.9118.0229.5618.1216.208.6822.2616.4714.1411.9719.2816.8319.330.51-2.65-5.08-19.14-1.082.19-1.664.363.214.854.904.414.93
101,400.0020,280.0011,266.6712.5014.2920.8326.0931.8234.8539.3239.8340.9043.2744.1944.0144.2344.7444.7846.9846.4245.3544.8045.0042.8242.0141.7240.8740.2035.9439.5938.4437.9138.1336.5435.4133.7732.1930.8329.38
000000.010.010.020.050.130.140.160.20.230.270.350.420.490.550.670.760.860.961.091.251.491.461.41.191.061.021.031.01000000
-5-14-9-10-4-2151312124565786710511814817520723426831132625617823-253-346-57-2756-212132623424174590
-180.00-35.7111.11-60.00-50.00-150.00400.00160.00-7.69-275.0044.4420.00-14.1056.7212.3825.4218.2418.2913.0414.5316.044.82-21.47-30.47-87.08-1,200.0036.76-83.53-52.63-307.41-137.50-1,114.2923.0030.5321.9310.07-
8.28.48.48.422.329.943.145.16180.484.490.292.292.490.690.589.988.386.78787.48787.486.286.285.685.687.19191.591.892.492.4000000
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Details

Keystats

ⓘ

Revenue and Growth

The Stericycle Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Stericycle is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETS
CASH BALANCE (M)
RECEIVABLES (M)
OTHER REC. (M)
INVENTORIES (M)
OTHER CURRENT LIAB. (M)
CURRENT ASSETS (M)
TANGIBLE ASSETS (B)
LONG-T. INVEST. (M)
LONG-T. REC. (M)
INTANGIBLE ASSETS (B)
GOODWILL (B)
OTHER NON-CURRENT ASSETS (M)
NON-CURRENT ASSETS (B)
TOTAL ASSETS (B)
LIABILITIES
COMMON STOCK (M)
ADDITIONAL PAID-IN CAPITAL (B)
RETAINED EARNINGS (B)
OTHER EQUITY (M)
UNREAL. GAINS/LOSSES (M)
EQUITY (B)
LIABILITIES (M)
PROVISIONS (M)
OTHER SHORT-TERM LIAB. (M)
SHORT-TERM DEBTS (M)
LONG-TERM DEBT PORTION (M)
SHORT-TERM REC. (M)
LONG-T. LIAB. (B)
DEFERRED TAXES (M)
OTHER LIAB. (M)
LONG-T. LIABILITIES (B)
DEBT (B)
TOTAL CAPITAL (B)
199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                           
1.20.117.75.41.819.62.9138.97.97.98.51618.410.516.995.522.931.867.622.655.744.242.234.334.753.355.65635.3
4.83.74.810.316.648.371.265.36259.774.9103.7130.4157.4168.6179.8214.9290.9322.2389465.5614.5634.9624.1599.6544.3380.7420.4414.5553.9
00000004.30.82.23.43.2000000000000000000
0.60.50.40.71.323.264.53.24.35.3000000000000000000
1.10.80.90.82.17.613.79.718.224.62523.372.234.545.449.958.276.887.283.763.891.694.5147.1113.4127.6118.599.588.282.3
7.75.123.817.221.877.59198.394.497.6115.5144218.6210.3224.5246.6368.6390.6441.2540.3551.9761.8773.6813.4747.3706.6552.5575.5558.7671.5
0.010.010.010.010.020.080.070.080.090.10.140.140.160.190.210.250.270.290.340.360.460.670.720.740.741.231.071.061.111.17
000000000000000000000000000000
000000027.77.79.510.7000000000000000000
00000000.010.020.030.050.060.120.150.170.270.380.550.670.720.911.841.861.791.641.421.090.960.810.69
0.010.010.020.030.050.420.420.410.450.460.520.690.811.031.141.391.61.912.072.232.423.763.593.63.222.982.822.822.782.76
0.70.60.53.43.722.114.38.89.18.969.922.518.821.326.631.432.33737.132.53729.638.4104.892.356.461.664.866.4
0.020.020.030.040.080.520.510.520.570.610.720.91.111.41.531.942.272.793.113.353.826.36.216.175.715.735.034.94.784.68
0.030.020.060.060.10.60.60.610.670.710.831.051.331.611.762.182.643.183.553.894.377.076.986.996.466.445.585.475.335.35
                                                           
62.90.10.10.10.169.371.645.328.421.30.40.40.90.90.90.80.90.80.90.90.80.80.80.90.90.90.90.90.90.9
00.050.080.080.090.140.140.230.280.290.30.260.250.20.070.050.0500.120.20.291.141.171.151.161.211.231.261.291.32
-0.03-0.04-0.04-0.04-0.03-0.02-0.010.010.050.120.190.260.370.490.630.811.021.241.461.611.741.872.012.031.791.441.381.351.411.39
-13000000-4-0.20.52.50.55.230.5-32.1-12.3-14.1-43.6-39.1-56.5-138.4-282.6-362.3-283-362.3-318.1-187.4-218.8-276.9-184.5
0000000000000000-2.7-2.40000-5.3-4-300000
0.020.010.040.040.050.190.210.280.360.430.50.520.630.710.670.851.051.21.541.751.92.732.812.92.592.332.432.42.422.52
1.31.91.51.96.517.916.113.314.315.71827.9254033.647.654.866.680.989.1114.6149.2172.3195.2225.8220.1181.2218.9213.5212.1
2.723.876.526.921.424.429.137.235.244.557.164.186.184.7131.7134.3116107.4113.9197.3210.2546.9298.5336324407.4287.4315.4
0.60.60.70.32.20.10.58.76.211.216.814.337.223.521.122.530.725.446.469.2100.479.483.2100.889.895.8100.983.995.8169.9
00000004.40.200000000000004.4714.81.901.62.91
0.60.33.23.15.55.75.112.63.94.813.21222.72238.965.991.4100.587.8150.4132161.472.8119.5104.3103.19119.922.319.6
5.24.89.212.320.750.643.163.453.768.983.298.7142149.6179.7220.7308.6326.8331.1416.1460.9587.3542.9969.4733.2756.9697.1731.7621.9718
00.01000.020.360.350.270.220.160.190.350.440.610.750.921.011.281.271.281.533.042.882.622.662.561.691.591.481.28
00000003.230.742.357.571.5105.5125147.3171.7222.6313.7359.8396.1403.8608.3645.4371.1307.3295.1380.4411427420.5
0.20.51.40.502.43.63.23.74.47.66.912.25.57.910.213.325.130.327.564.181.498.1123.9154491380.9337.8376.7413.4
0.010.010.0100.020.360.350.270.260.210.260.430.560.740.911.11.251.621.661.723.733.623.113.133.352.452.342.292.11
0.010.010.020.020.040.410.390.340.310.280.340.530.70.891.091.331.561.951.992.122.464.324.164.083.864.13.153.072.912.83
0.030.020.060.060.10.60.60.610.670.710.831.051.331.611.762.172.613.153.533.874.357.056.976.986.456.435.585.475.335.35
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Stericycle provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Stericycle's financial health and stability.

Assets

Stericycle's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Stericycle must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Stericycle after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Stericycle's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)
DEPRECIATION (M)
DEFERRED TAXES (M)
CHANGES IN WORKING CAPITAL (M)
NON-CASH ITEM (M)
PAID INTEREST (M)
PAID TAXES (M)
NET CASH FLOW FROM OPERATING ACTIVITIES (M)
CAPITAL EXPENDITURES (M)
CASH FLOW FROM INVESTING ACTIVITIES (M)
CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)
INTEREST INCOME AND EXPENSES (M)
NET DEBT CHANGE (B)
NET CHANGE IN EQUITY (M)
CASH FLOW FROM FINANCING ACTIVITIES (B)
CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)
TOTAL DIVIDENDS PAID (M)
NET CHANGE IN CASH FLOW (M)
FREE CASH FLOW (M)
SHARE-BASED COMPENSATION (M)
1993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
-6-5-4-2151414144565786710511814817621023726931332826820743-245-346-55-2656-21
01123492325151721212731344053667688104127252249255272233223232216
000000-7091691313121726222631223016-107-290-34-33322920-2
-2-210-4-4-5-2841117-12-20110-23341-2525-28-9-1743376-257-5014739-132-56
00000001111013131231715198119182639701514704221986447140
0000002373324131113273129242843470576888859310175577270
00000122231625283045526600000125111128266-83-7-119
-7-600041110649812311494160174210277325306387405448386560508165248530303200243
-3-10-1-1-4-3-11-16-14-21-33-26-36-48-47-39-48-53-65-73-86-114-136-143-130-194-119-116-132-131
-3-30-13-3-23-425-15-36-49-57-105-156-201-135-132-350-245-504-288-235-462-2,533-195-193-147-104381-90-84-43
0-10-12-2-19-421-4-20-34-36-71-129-165-86-85-310-197-450-223-161-376-2,419-59-50-1690500264787
0000000000000000000000000000000
000-0-00.010.33-0.01-0.07-0.06-0.060.010.110.070.050.060.140.010.23-0.13-0.030.11.53-0.29-0.26-0-0.15-0.88-0.2-0.1-0.21
83028001162525-2-21-46-26-87-149-60-44-9216-121-142693-34-242190-3-5-5
0.01000.03-00.010.43-0.01-0.02-0.05-0.07-0.010.060.05-0.03-0.080.08-0.010.14-0.09-0.14-0.032.19-0.38-0.32-0.03-0.14-0.89-0.21-0.11-0.22
000000-1000000-18797182231610-24-8-3-2-9-8-40-1
0000000000000000000000-10-39-36-2500000
-3-6-111-6-418-1610-4-10053-8663-56832-4433-11-2-701820-20
-11.2-8.6-1.6-0.9-1.30.68-1.148.283.9102.981.368123.8125.6163.1237.3277.4252.8322.2332.2362271.3424.6365.634.953.8410.7186.268112
0000000000000000000000000000000

Stericycle stock margins

The Stericycle margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Stericycle. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Stericycle.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Stericycle's sales revenue. A higher gross margin percentage indicates that the Stericycle retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Stericycle's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Stericycle's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Stericycle's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Stericycle. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Stericycle's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Stericycle Margin History

Stericycle Gross marginStericycle Profit marginStericycle EBIT marginStericycle Profit margin
2029e38.15 %0 %0 %
2028e38.15 %0 %13.98 %
2027e38.15 %0 %13.25 %
2026e38.15 %16.3 %11.39 %
2025e38.15 %13.62 %9.18 %
2024e38.15 %11.28 %7.71 %
202338.15 %10.04 %-0.8 %
202237.92 %7.38 %2.07 %
202138.43 %8.86 %-1.05 %
202039.62 %9.52 %-2.14 %
201935.96 %8.07 %-10.48 %
201840.21 %13.18 %-7.27 %
201740.86 %15.04 %0.65 %
201641.74 %16.64 %5 %
201542.02 %22.19 %8.6 %
201442.82 %24.02 %12.78 %
201345.02 %25.85 %14.53 %
201244.81 %24.5 %14.01 %
201145.39 %25.32 %14.01 %
201046.47 %27.14 %14.44 %
200946.96 %27.61 %14.92 %
200844.75 %26 %13.72 %
200744.8 %25.86 %12.69 %
200644.31 %26.03 %13.34 %
200543.97 %27.48 %11.03 %
200444.21 %28.59 %15.15 %

Stericycle Stock Sales Revenue, EBIT, Earnings per Share

The Stericycle earnings per share therefore indicates how much revenue Stericycle has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Stericycle earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Stericycle's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Stericycle’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Stericycle's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Stericycle Revenue, EBIT and net profit per share

DateStericycle Sales per ShareStericycle EBIT per shareStericycle Earnings per Share
2029e37.35 undefined0 undefined0 undefined
2028e35.6 undefined0 undefined4.98 undefined
2027e34.09 undefined0 undefined4.52 undefined
2026e32.5 undefined0 undefined3.7 undefined
2025e31 undefined0 undefined2.85 undefined
2024e30.03 undefined0 undefined2.32 undefined
202328.78 undefined2.89 undefined-0.23 undefined
202229.27 undefined2.16 undefined0.61 undefined
202128.83 undefined2.55 undefined-0.3 undefined
202029.24 undefined2.78 undefined-0.63 undefined
201936.36 undefined2.94 undefined-3.81 undefined
201840.02 undefined5.28 undefined-2.91 undefined
201741.83 undefined6.29 undefined0.27 undefined
201641.62 undefined6.92 undefined2.08 undefined
201534.64 undefined7.69 undefined2.98 undefined
201429.65 undefined7.12 undefined3.79 undefined
201324.52 undefined6.34 undefined3.56 undefined
201221.99 undefined5.39 undefined3.08 undefined
201119.18 undefined4.85 undefined2.69 undefined
201016.54 undefined4.49 undefined2.39 undefined
200913.58 undefined3.75 undefined2.03 undefined
200812.27 undefined3.19 undefined1.68 undefined
200710.38 undefined2.68 undefined1.32 undefined
20068.72 undefined2.27 undefined1.16 undefined
20056.73 undefined1.85 undefined0.74 undefined
20045.59 undefined1.6 undefined0.85 undefined

Stericycle business model

Stericycle Inc. is a globally operating company specialized in waste management in various industries. It was founded in 1989 by Mark Miller and John Patience in Chicago, with a focus on disposing of medical waste from hospitals. Since then, the company has expanded significantly and now operates in over 20 countries worldwide. Stericycle's business model is based on the disposal of hazardous and non-hazardous waste in various sectors such as healthcare, pharmaceuticals, retail, industry, and government. The company offers a wide range of products and services, including collection, transportation, recycling, and disposal. The different divisions within the company are tailored to meet the specific needs of each industry. For example, Stericycle Medical Solutions handles the disposal of medical waste such as syringes, medical devices, and pharmaceutical products. The Shred-It division specializes in document destruction, while the Expert Solutions division offers consulting and training services. In addition to its services, Stericycle also produces a wide range of products tailored to the needs of different industries. This includes specialized containers for medical waste, shredders for documents, and recycling bins for various materials. The company also offers safety clothing and training materials. In summary, Stericycle Inc. is an internationally operating company specializing in waste management across various industries. Its business model is based on the disposal of hazardous and non-hazardous waste in sectors such as healthcare, pharmaceuticals, retail, industry, and government. The company offers a wide range of products and services, including collection, transportation, recycling, and disposal. Its various divisions are tailored to meet the specific needs of each industry, and it produces various products such as containers, shredders, and recycling bins. Stericycle is one of the most popular companies on Eulerpool.com.

Stericycle SWOT Analysis

Strengths

Stericycle Inc has a strong reputation in the waste management industry, with over 30 years of experience. The company has established trust and credibility among its customers.

Stericycle Inc offers a comprehensive range of waste management services, including medical, pharmaceutical, and hazardous waste disposal. This allows the company to cater to various industries and meet diverse needs.

The company has a widespread network of facilities and a large fleet of vehicles, enabling efficient pickup, transportation, and disposal of waste materials.

Weaknesses

Stericycle Inc faces increasing competition in the waste management sector. The company needs to stay innovative and adapt to changing market trends to maintain its market share.

Some customers may perceive Stericycle Inc's services as costly compared to other waste management providers. This can potentially impact the company's ability to attract price-sensitive clients.

Inefficient waste management processes or delays could harm Stericycle Inc's reputation and result in customer dissatisfaction.

Opportunities

With the growing concern for environmental sustainability, Stericycle Inc can capitalize on the increasing demand for eco-friendly waste disposal methods. Developing and promoting green initiatives can lead to new business opportunities.

Expanding into emerging markets and partnering with healthcare organizations and pharmaceutical companies can create new revenue streams for Stericycle Inc.

Advancements in technology can be leveraged by Stericycle Inc to enhance operational efficiency, streamline waste management processes, and improve overall customer experience.

Threats

Changes in regulations related to waste management and disposal can pose a threat to Stericycle Inc's operations. Compliance with stringent regulatory requirements may increase costs and affect profitability.

Economic downturns or reduced healthcare spending can impact the demand for Stericycle Inc's services, as healthcare providers may look for ways to cut costs.

The emergence of new competitors or consolidation within the waste management industry can intensify competition and potentially erode Stericycle Inc's market share.

Stericycle Revenue by Segment

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Details
Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Stericycle Revenue by Segment

Segmente20222021202020192018201720162015201420112010
Medical waste and compliance solutions----1.62 B USD------
Regulated Waste and Compliance Services329.4 M USD396.5 M USD379 M USD--------
Secure information destruction services----911 M USD------
Regulated and Compliance Solutions--------758.81 M USD--
Secure information destruction services member------747.51 M USD----
Manufacturing and industrial services----329.2 M USD351.1 M USD-----
Manufacturing and industrial services member------382.92 M USD----
Secure Information Destruction Services112.2 M USD113.9 M USD98 M USD--------
Hazardous waste solutions----314.1 M USD------
Communication and related services---219.2 M USD-------
Communication services----184.1 M USD------
Expert solutions----129 M USD------
Recall and returns solutions-------102.83 M USD---
Recall and Returns Solutions--------81.36 M USD--
Communication and Related Services--9.3 M USD--------

  • 3 years

  • 5 years

  • Max

Details
Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Stericycle Revenue by Segment

Segmente20222021202020192018201720162015201420112010
Regulated waste and compliance services---1.89 B USD-2.02 B USD2.06 B USD----
Secure information destruction services---901.9 M USD-823.4 M USD-----
Medical waste and compliance services---1.57 B USD-------
Regulated and compliance solutions-------820.88 M USD---
Communication and related services-----382.6 M USD-----
Communication and related services member------370.5 M USD----
Hazardous waste service---321.3 M USD-------
Manufacturing and industrial services---295 M USD-------
Communication related services---219.2 M USD-------
Communication services---133.8 M USD-------
Expert solutions---85.4 M USD-------

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Details
Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Stericycle Revenue by Segment

Segmente20222021202020192018201720162015201420112010
Domestic and Canada regulated waste and compliance services----2.57 B USD2.55 B USD2.51 B USD----
North America2.26 B USD2.14 B USD2.19 B USD--------
United States-------2.17 B USD1.8 B USD--
International regulated waste and compliance services---579.3 M USD655.1 M USD707.6 M USD751.68 M USD----
International441.6 M USD510.4 M USD486.3 M USD----441.23 M USD407.08 M USD--
Other-----321.2 M USD-----
Regulated Waste Management Service---------211.32 M USD-
Regulated returns and recall management services---------117.18 M USD-

  • 3 years

  • 5 years

  • Max

Details
Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Stericycle Revenue by Segment

Segmente20222021202020192018201720162015201420112010
North America regulated waste and compliance services---2.54 B USD-------
International regulated and compliance services---579.3 M USD239.6 M USD------
All Other---185.4 M USD256.7 M USD------
Domestic and Canada RCS----157.2 M USD------

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Details
Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Stericycle Revenue by Segment

Segmente20222021202020192018201720162015201420112010
Regulated Waste Management Service----------957.4 M USD
Other------301.8 M USD----
Regulated returns and recall management services----------126.17 M USD

Stericycle Revenue by Region

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Details
Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Stericycle Revenue by Segment

DateCanadaEMEAEuropeForeign CountriesForeign CountryInternationalOther countriesOther CountriesOther geographical areaOther international countriesOther international countries excluding US and EuropeTotal InternationalUnited States
2023--384 M USD---159.2 M USD-----2.12 B USD
2022--385.9 M USD---196.6 M USD-----2.12 B USD
2021-------651.7 M USD----2 B USD
2020--377.7 M USD----608.2 M USD-230.5 M USD--2.07 B USD
2019151.6 M USD448.5 M USD379.3 M USD----730.9 M USD130.8 M USD-351.5 M USD-2.58 B USD
2017--436.2 M USD------427.6 M USD-863.8 M USD2.72 B USD
2016--485.98 M USD--904.89 M USD---418.92 M USD--2.66 B USD
2011----211.32 M USD-------1.21 B USD
2010---355.82 M USD--------1.08 B USD
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Stericycle Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Stericycle historical P/E ratio, EBIT multiple, and P/S ratio

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Stericycle shares outstanding

The number of shares was Stericycle in 2024 — This indicates how many shares 92.4 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Stericycle earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Stericycle's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Stericycle’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Stericycle's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Stericycle stock splits

In Stericycle's history, there have been no stock splits.
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Stericycle.

Stericycle latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20240.57 0.53  (-6.21 %)2024 Q3
6/30/20240.58 0.5  (-13.78 %)2024 Q2
3/31/20240.57 0.57  (0.6 %)2024 Q1
12/31/20230.48 0.54  (13.33 %)2023 Q4
9/30/20230.46 0.43  (-7.15 %)2023 Q3
6/30/20230.5 0.43  (-13.67 %)2023 Q2
3/31/20230.45 0.49  (10.01 %)2023 Q1
12/31/20220.61 0.6  (-2.28 %)2022 Q4
9/30/20220.59 0.65  (9.69 %)2022 Q3
6/30/20220.49 0.48  (-1.76 %)2022 Q2
1
2
3
4
5
...
11

Eulerpool ESG Scorecard© for the Stericycle stock

Eulerpool World ESG Rating (EESG©)

65/ 100

🌱 Environment

53

👫 Social

64

🏛️ Governance

77

Environment

Scope 1 - Direct Emissions
414,485
Scope 2 - Indirect emissions from purchased energy
31,398
Scope 3 - Indirect emissions within the value chain
641,133
Total CO₂ emissions
445,883
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees22
Percentage of women in management
Percentage of Asian employees2
Share of Asian management2.49
Percentage of Hispanic/Latino employees21
Hispano/Latino Management share15.65
Percentage of Black employees25
Black Management Share11.95
Percentage of white employees44
White Management Share66.38
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Stericycle shareholders

%
Name
Stocks
Change
Date
0.50866 % Thematics Asset Management SAS470,000-22,4716/30/2024
0.28081 % AQR Arbitrage, LLC259,470-31,4869/30/2024
0.27371 % Impax Asset Management LLC252,90609/30/2024
0.27062 % Raymond James & Associates, Inc.250,052-329,2089/30/2024
0.22009 % C&J Wealth Advisors203,361203,3613/31/2024
0.12929 % Vest Financial, LLC119,467109,5599/30/2024
0.11019 % Asset Management One Co., Ltd.101,811101,8116/30/2024
0.10047 % BCK Capital Management LP92,83413,9259/30/2024
0.09920 % Columbia Threadneedle Investments (UK)91,66305/31/2023
0.09363 % Texas Permanent School Fund86,5115,5366/30/2024
1
2
3
4
5
...
10

Stericycle Executives and Management Board

Mr. Joseph Reuter

(62)
Stericycle Executive Vice President, Chief People Officer
Compensation 937,999

Mr. Michael Weisman

(65)
Stericycle Executive Vice President, Chief Ethics and Compliance Officer

Mr. Dominic Culotta

(60)
Stericycle Executive Vice President, Chief Engineer and Chief Transformation Officer

Mr. Richard Moore

(62)
Stericycle Executive Vice President - North American Operations

Mr. Rafael Carrasco

Stericycle Executive Officer, Director (since 2024)
1
2
3

Stericycle Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
US Ecology, Inc. Stock
US Ecology, Inc.
SupplierCustomer0,69-0,41-0,26-0,60-0,41-0,14
Renovare Environmental Stock
Renovare Environmental
SupplierCustomer0,560,810,890,760,940,60
Coupa Software Incorporated Stock
Coupa Software Incorporated
SupplierCustomer-0,130,740,830,760,910,63
SpartanNash Company Stock
SpartanNash Company
SupplierCustomer-0,630,27-0,01-0,55-0,86-0,73
1

Most common questions regarding Stericycle

What values and corporate philosophy does Stericycle represent?

Stericycle Inc embodies a strong set of values and corporate philosophy. The company is committed to providing safe, sustainable, and compliant solutions for managing regulated waste and protecting the environment. With a focus on integrity, accountability, and customer satisfaction, Stericycle aims to be the preferred partner in healthcare, pharmaceutical, and retail industries. They prioritize employee safety, diversity, and community engagement, fostering a positive and inclusive work environment. By continuously innovating and adhering to strict ethical standards, Stericycle demonstrates its dedication to delivering exceptional waste management services while upholding its commitment to social responsibility and sustainability.

In which countries and regions is Stericycle primarily present?

Stericycle Inc is primarily present in multiple countries and regions across the globe. The company operates and serves customers in the United States, Canada, Mexico, Argentina, Brazil, Chile, Colombia, Costa Rica, Puerto Rico, Peru, India, Ireland, Spain, Portugal, Germany, Austria, Belgium, Denmark, Finland, France, Italy, Netherlands, Norway, Poland, Sweden, Switzerland, United Kingdom, Australia, New Zealand, Hong Kong, Japan, Malaysia, Singapore, South Korea, Taiwan, and Thailand. With a wide geographic presence, Stericycle Inc offers its comprehensive services and solutions to numerous markets worldwide.

What significant milestones has the company Stericycle achieved?

Stericycle Inc, a leading medical waste management company, has achieved significant milestones since its inception. The company expanded its services globally, delivering comprehensive solutions for healthcare waste management, compliance, and secure data destruction. Stericycle Inc successfully established itself as a trusted partner in the healthcare industry, offering safe and environmentally-friendly disposal solutions while ensuring regulatory compliance. The company's dedication to innovation resulted in groundbreaking technologies, such as the Steri-Smart™ System, streamlining waste collection and disposal processes for healthcare facilities. Stericycle Inc's commitment to customer satisfaction and continuous improvement has contributed to its growth, making it a noteworthy player in the industry.

What is the history and background of the company Stericycle?

Stericycle Inc, based in Lake Forest, Illinois, is a leading provider of regulated medical waste management and secure information destruction services. Founded in 1989 by Mark C. Miller, Stericycle initially focused on collecting and treating medical waste from healthcare facilities. Over the years, the company expanded its services to include hazardous waste disposal, pharmaceutical returns, product recalls, and compliance training. Stericycle has grown through strategic acquisitions and now serves customers in the healthcare, retail, and industrial sectors worldwide. This global presence and diversified service portfolio have established Stericycle as a trusted and reliable partner for managing complex waste and compliance needs.

Who are the main competitors of Stericycle in the market?

The main competitors of Stericycle Inc in the market include Waste Management Inc, Republic Services Inc, and Clean Harbors Inc.

In which industries is Stericycle primarily active?

Stericycle Inc is primarily active in the waste management industry.

What is the business model of Stericycle?

Stericycle Inc's business model revolves around providing comprehensive solutions for managing regulated waste and providing secure information destruction services. As a leading provider in the industry, Stericycle offers a range of services, including medical waste disposal, hazardous waste management, shredding, and compliance training. By focusing on helping businesses and healthcare organizations comply with stringent regulations, Stericycle ensures the safety and protection of employees, patients, and the environment. With its innovative solutions and commitment to quality, Stericycle Inc has established itself as a trusted partner in waste management and secure information destruction.

What is the P/E ratio of Stericycle 2025?

The P/E ratio cannot be calculated for Stericycle at the moment.

What is the P/S ratio of Stericycle 2025?

The P/S cannot be calculated for Stericycle currently.

What is the Quality Investing of Stericycle?

The Quality Investing cannot be calculated for Stericycle at the moment.

What is the revenue of Stericycle 2025?

The expected Stericycle revenue is 2.86 B USD.

How high is the profit of Stericycle 2025?

The expected Stericycle profit is 262.95 M USD.

What is the business model of Stericycle

Stericycle Inc is a provider of waste disposal and compliance solutions in the fields of health and environment. The company offers its services to various industries, including healthcare, life sciences, retail, government, education, and manufacturing. 1. Regulated medical disposal: Stericycle is a leading provider of medical disposal services for hospitals, doctor's offices, labs, and other facilities that produce healthcare-related waste. The company offers options for waste collection, transportation, treatment, and destruction. 2. Compliance solutions: Stericycle helps companies comply with regulations and guidelines in the fields of health and environment. The company offers training, consulting, practice review, and the provision of informational materials. 3. Communication and marketing solutions: Stericycle provides support to companies in developing, designing, and delivering marketing and customer communication content. The company's services include printing and mailing services, email management, and online tools. 4. Recall and retrieval solutions: Stericycle offers services for the retrieval of products that are defective or dangerous. The company works with customers to plan and coordinate the recall process, and also provides retrieval solutions to recover the products. In addition to these four main divisions, Stericycle also offers a wide range of products and services, including medical maintenance packages, specialized waste bins and containers, medical equipment, as well as safety and compliance products. Stericycle's business model is based on providing solutions to companies that deal with waste disposal and compliance in the fields of health and environment. Stericycle offers comprehensive services that enable customers to comply with legal requirements, safely dispose of waste, and minimize risks to public health and the environment. Stericycle aims to develop innovative services and solutions to meet the changing needs of its customers. The company invests in new technologies and acquires companies to expand its services and improve its offerings. Overall, Stericycle's business model is aligned with the needs and priorities of its customers. By providing reliable, secure, and comprehensive solutions, the company has established a strong position in the waste disposal and compliance solutions industry.

What is the Stericycle dividend?

Stericycle pays a dividend of 0 USD distributed over payouts per year.

How often does Stericycle pay dividends?

The dividend cannot currently be calculated for Stericycle or the company does not pay out a dividend.

What is the Stericycle ISIN?

The ISIN of Stericycle is US8589121081.

What is the Stericycle WKN?

The WKN of Stericycle is 902518.

What is the Stericycle ticker?

The ticker of Stericycle is SRCL.

How much dividend does Stericycle pay?

Over the past 12 months, Stericycle paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Stericycle is expected to pay a dividend of 0 USD.

What is the dividend yield of Stericycle?

The current dividend yield of Stericycle is .

When does Stericycle pay dividends?

Stericycle pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Stericycle?

Stericycle paid dividends every year for the past 0 years.

What is the dividend of Stericycle?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Stericycle located?

Stericycle is assigned to the 'Industry' sector.

Wann musste ich die Aktien von Stericycle kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Stericycle from 9/21/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/21/2025.

When did Stericycle pay the last dividend?

The last dividend was paid out on 9/21/2025.

What was the dividend of Stericycle in the year 2024?

In the year 2024, Stericycle distributed 0 USD as dividends.

In which currency does Stericycle pay out the dividend?

The dividends of Stericycle are distributed in USD.

All fundamentals about Stericycle

Our stock analysis for Stericycle Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Stericycle Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.